Storia in 8 fonti

Supreme Court rejects challenge to Medicare drug price negotiation

The rejection may make the pharma firms remaining lawsuits more difficult.

Raccontata daapnews.comeu.usatoday.comedition.cnn.comendpoints.newsstatnews.compbs.orgupi.comfiercepharma.com

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

statnews.comStai leggendo1 mesi fa

Supreme Court rejects challenge to Medicare drug price negotiation

The rejection may make the pharma firms remaining lawsuits more difficult.

originale

apnews.com1 mesi fa

Supreme Court rejects appeals from drug manufacturers over Medicare price negotiations

The Supreme Court has rejected appeals from pharmaceutical companies that object to negotiating Medicare drug prices with the federal government.

Leggi questa versione → originale

edition.cnn.com1 mesi fa

Supreme Court rejects Big Pharma appeals challenging negotiated drug prices in Medicare | CNN Politics

The US Supreme Court on Monday rejected a series of appeals from several of the nation’s largest drugmakers challenging a program that is expected to save taxpayers and the federal government billions of dollars by…

Leggi questa versione → originale

pbs.org1 mesi fa

Supreme Court rejects appeals from drug manufacturers over Medicare price negotiations with government

The negotiation program was created as part of the 2022 Inflation Reduction Act, which capped years of debate over whether the federal government should be allowed to haggle directly with manufacturers over the prices…

Leggi questa versione → originale

eu.usatoday.com1 mesi fa

Pharma companies want to block Medicare drug discounts. Supreme Court weighs in

Pharmaceutical companies are trying to prevent Medicare from negotiating discounts for drugs. Their legal challenges have been unsuccessful.

Leggi questa versione → originale

endpoints.news1 mesi fa

The Supreme Court won't take up IRA cases

The Supreme Court says it won’t wade into the pharma industry’s yearslong legal battle over Medicare drug price negotiations. The justices declined to review multiple cases brought by AstraZeneca, J&J, Bristol Myers…

Leggi questa versione → originale

Timeline cronologica

1. lunedì 18 maggio 2026·apnews.com
   

   Supreme Court rejects appeals from drug manufacturers over Medicare price negotiations

   The Supreme Court has rejected appeals from pharmaceutical companies that object to negotiating Medicare drug prices with the federal government.

2. lunedì 18 maggio 2026·eu.usatoday.com
   

   Pharma companies want to block Medicare drug discounts. Supreme Court weighs in

   Pharmaceutical companies are trying to prevent Medicare from negotiating discounts for drugs. Their legal challenges have been unsuccessful.

3. lunedì 18 maggio 2026·edition.cnn.com
   

   Supreme Court rejects Big Pharma appeals challenging negotiated drug prices in Medicare | CNN Politics

   The US Supreme Court on Monday rejected a series of appeals from several of the nation’s largest drugmakers challenging a program that is expected to save taxpayers and the…

4. lunedì 18 maggio 2026·endpoints.news
   

   The Supreme Court won't take up IRA cases

   The Supreme Court says it won’t wade into the pharma industry’s yearslong legal battle over Medicare drug price negotiations. The justices declined to review multiple cases…

5. lunedì 18 maggio 2026·statnews.com
   

   Supreme Court rejects challenge to Medicare drug price negotiation

   The rejection may make the pharma firms remaining lawsuits more difficult.

6. lunedì 18 maggio 2026·pbs.org
   

   Supreme Court rejects appeals from drug manufacturers over Medicare price negotiations with government

   The negotiation program was created as part of the 2022 Inflation Reduction Act, which capped years of debate over whether the federal government should be allowed to haggle…

7. lunedì 18 maggio 2026·upi.com
   

   Supreme Court rejects appeal from drugmakers over price negotiations - UPI.com

   The U.S. Supreme Court ruled Monday it will not take up an appeal from a group of drug makers attempting to block negotiations for lower drug prices.

8. lunedì 18 maggio 2026·fiercepharma.com
   

   Supreme Court declines to hear IRA challenges from Novo, AZ and more

   Even as a new drug pricing specter rears its head in President Donald Trump’s “Most Favored Nation” policies, drugmakers continue to fight Medicare price negotiations under the…